Intersect ENT

company

About

Intersect ENT provides therapy solutions that enable ENT physicians to improve patients' quality of life.

  • 251 - 500

Details

Last Funding Type
Series C
Last Funding Money Raised
$31.01M
Industries
Health Care,Medical,Pharmaceutical
Founded date
Jan 1, 2003
Number Of Employee
251 - 500
Operating Status
Active

Intersect ENT Inc. (formerly Sinexus) is a medical device company pioneering novel therapies for Ear, Nose, and Throat surgeons to utilize in providing improved treatment for their patients. The company was founded in 2003 by Don Eaton and is headquartered in Menlo Park, California, United States.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$61.01M
Intersect ENT has raised a total of $61.01M in funding over 2 rounds. Their latest funding was raised on Feb 25, 2013 from a Series D round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 25, 2013 Series D $30M 1 Norwest Venture Partners Detail
Oct 28, 2010 Series C $31.01M 2 Detail

Investors

Number of Lead Investors
Number of Investors
1
2
Intersect ENT is funded by 2 investors. Norwest Venture Partners and Medtronic are the most recent investors.
Investor Name Lead Investor Funding Round
Norwest Venture Partners Yes Series D
Medtronic Series C